During the past decade, Cape Fear Retinal Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cape Fear Retinal Associates" are "Diabetic Macular Edema" (1 trials) and "Diabetic Retinopathy" (1 trials). Many other conditions were trialed in "Cape Fear Retinal Associates" in a lesser frequency.

Most popular intervention types in "Cape Fear Retinal Associates" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Intravitreal Ranibizumab 0.5 mg Injection" (2 trials) and "PDS Implant Pre-Filled with 100 mg/mL Ranibizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cape Fear Retinal Associates" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Cape Fear Retinal Associates". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Cape Fear Retinal Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cape Fear Retinal Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".